Please use this identifier to cite or link to this item:
Title: Coagulation abnormalities, bleeding, thrombosis, and management of patients with acute liver failure in Australia and New Zealand.
Austin Authors: Warrillow, Stephen J ;Fisher, Caleb ;Tibballs, Heath;Bailey, Michael;McArthur, Colin;Lawson-Smith, Pia;Prasad, Bheemasenachar;Anstey, Matthew;Venkatesh, Bala;Dashwood, Gemma;Walsham, James;Holt, Andrew;Wiersema, Ubbo;Gattas, David;Zoeller, Matthew;Garcia Alvarez, Mercedes;Bellomo, Rinaldo 
Affiliation: Australian and New Zealand Intensive Care Research Centre, Monash University School of Public Health and Preventive Medicine, Victoria, Melbourne, Australia
Department of Intensive Care, Royal Prince Alfred Hospital, Sydney, Australia
Department of Critical Care Medicine, Auckland City Hospital, Auckland, New Zealand
Department of Intensive Care, Princess Alexandra Hospital, Brisbane, Australia
Department of Intensive Care, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
Intensive Care
South Metropolitan Health Service, Rockingham, Western Australia, Australia
Department of Medicine and Surgery, The University of Melbourne, Melbourne, Victoria, Australia
Medical Research Institute of New Zealand, Auckland, New Zealand
Centre for Integrated Critical Care, The University of Melbourne, Melbourne, Australia
Department of Intensive Care, Royal Melbourne Hospital, Melbourne, Australia
Department of Intensive Care, Flinders Medical Centre, Adelaide, South Australia, Australia
Department of Anesthesiology and Pain Medicine, Hospital Santa Creu i Sant Pau, University of Barcelona, Barcelona, Spain
Data Analytics Research and Evaluation (DARE) Centre, Austin Health and The University of Melbourne, Heidelberg, Victoria, Australia
Issue Date: 5-Nov-2019
Date: 2019-11-05
Publication information: Journal of Gastroenterology and Hepatology 2020; 35(5): 846-854
Abstract: To study the management of coagulation and hematological derangements among severe acute liver failure (ALF) patients in Australia and New Zealand liver transplant intensive care units (ICUs). Analysis of key baseline characteristics, etiology, coagulation and hematological tests, use of blood products, thrombotic complications, and clinical outcomes during the first ICU week. We studied 62 ALF patients. The first day median peak international normalized ratio was 5.5 (inter-quartile range [IQR] 3.8-8.7), median longest activated partial thromboplastin time was 62 s (IQR 44-87), and median lowest fibrinogen was 1.1 (IQR 0.8-1.6) g/L. Fibrinogen was only measured in 85% of patients, which was less than other tests (P < 0.0001). Median initial lowest platelet count was 83 (IQR 41-122) × 109 /L. Overall, 58% of patients received fresh frozen plasma, 40% cryoprecipitate, 35% platelets, and 15% prothrombin complex concentrate. Patients with bleeding complications (19%) had more severe overall hypofibrinogenemia and thrombocytopenia. Thrombotic complications were less common (10% of patients), were not associated with consistent patterns of abnormal hemostasis, and were not immediately preceded by clotting factor administration and half occurred only after liver transplantation surgery. In ALF patients admitted to dedicated Australia and New Zealand ICUs, fibrinogen was measured less frequently than other coagulation parameters but, together with platelets, appeared more relevant to bleeding risk. Blood products and procoagulant factors were administered to most patients at variable levels of hemostatic derangement, and bleeding complications were more common than thrombotic complications. This epidemiologic information and practice variability provide baseline data for the design and powering of interventional studies.
DOI: 10.1111/jgh.14876
ORCID: 0000-0002-7240-4106
Journal: Journal of Gastroenterology and Hepatology
PubMed URL: 31689724
Type: Journal Article
Subjects: acute liver failure
encephalopathy emergency liver transplant
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Jul 22, 2024

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.